LAQ/5062

· Teva Pharmaceutical Industries, Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LAQ/5062, covering 2019-03-27 to 2019-03-27. Get the full timeline:

Most recent: Clinical Trial Update: An Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the Disease [Phase 2]

See pricing